Eyeaspis DE caps is a specially designed product that manages dry eye conditions in patients with Sjögren Syndrome.
Sjögren Syndrome is an autoimmune disease that affects the whole body and mainly the lacrimal and salivary glands, causing dry mouth and/or dry eyes. In addition to dry eyes, patients with Sjogren’s disease also experience meibomianitis. What dry eye has in common with meibomianitis is the disturbance of the balance in the tear film which is characterized by inflammation and eye symptoms.
Eyeaspis DE caps has a proven anti-inflammatory effect and provides fatty acids as the main ingredient of meibomian gland to produce the right quality and quantity of the lipid layer (meibum).
Key components of the lipid layer with a strong anti-inflammatory effect are ω-3 fatty acids such as eicosapentaenoic acid (EPA) which is essential fatty acid for general function of the organism and which the body cannot synthesize by itself.
Eyeaspis DE caps has a strong anti-inflammatory effect with the re-esterified EPA as the main ingredient and antioxidant effect due to maqui berry extract (35% delphinidins). In addition, Eyeaspis DE caps covers the basic needs of the body in vitamin D3 with 1000 IU and vitamin B12.
Commercial rights & brand holder: Aniva International S.A.
The product should not be used as a substitute of a well-balanced diet. This product is not intended to prevent, treat or cure any human disease.
